FDA warns of kidney disorders, MI and stroke with Trasylol

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1089卷 / 1期

关键词：

Myocardial Infarction; Healthcare Provider; Artery Bypass; Bypass Graft; Aprotinin;

D O I：

10.2165/00128415-200610890-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] FDA warns of MI, death risk with regadenoson, adenosine
[J]. Reactions Weekly, 2013, 1481 (1) : 3 - 3
[2] FDA warns of liver disorders with kavain
[J]. Reactions Weekly, 2002, 896 (1) : 2 - 2
[3] FDA advises caution for Trasylol
[J]. Reactions Weekly, 2006, 1122 (1) : 3 - 3
[4] FDA advises of updated Trasylol labelling
[J]. Reactions Weekly, 2007, 1133 (1) : 2 - 2
[5] FDA warns on primate xenotransplants
Butler, D
[J]. NATURE, 1999, 398 (6728) : 549 - 549
[6] FDA warns on primate xenotransplants
Declan Butler
[J]. Nature, 1999, 398 : 549 - 549
[7] FDA warns on mercury in tuna
Stephenson, J
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (02): : 171 - 171
[8] FDA warns andro makers
Mamula, PW
[J]. PHYSICIAN AND SPORTSMEDICINE, 2004, 32 (05): : 13 - 14
[9] FDA warns Wockhardt, Fosun
Tremblay, Jean-Francois
[J]. CHEMICAL & ENGINEERING NEWS, 2017, 95 (11) : 14 - 14
[10] FDA warns of asenapine hypersensitivity
[J]. Reactions Weekly, 2011, 1368 (1) : 2 - 2

← 1 2 3 4 5 →